Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0787
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2617
    -0.0005 (-0.04%)
     
  • USD/JPY

    151.3200
    -0.0520 (-0.03%)
     
  • Bitcoin USD

    69,927.90
    -476.30 (-0.68%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Thoratec up in after-hours trading on 2Q results

Thoratec 2nd-quarter net income and revenue top expectations, shares rise aftermarket

NEW YORK (AP) -- Shares of Thoratec Corp. gained ground in aftermarket trading Wednesday after the heart device maker's second-quarter net income and revenue beat Wall Street forecasts on better sales of its HeartMate pumps.

Net income rose 11 percent. Sales of its HeartMate pumps climbed 9 percent to $115.7 million on better international sales, including the launch of the device in Japan. HeartMate pumps are used in patients who are waiting for a heart transplant or in those too sick for heart transplant surgery.

Thoratec shares rose $2.83, or 8.6 percent, to $35.62 in aftermarket trading.

Net income was $23.2 million, or 40 cents per share, up from $20.8 million, or 35 cents per share. Excluding one-time items Thoratec made 52 cents per share over the three months ended June 29. Revenue rose 10 percent, to $130.5 million.

Analysts forecast 43 cents per share and $121.3 million in revenue, according to FactSet.

Thoratec now expects net income of $1.69 to $1.79 per share for this year. It had called for $1.76 to $1.86 per share but lowered its estimate to include costs related to an acquisition. It maintained its estimate of $490 million to $510 million in revenue.

Analysts are projecting net income of $1.73 per share and $494.2 million in revenue, on average.

Advertisement